Investor Stock List
Ranked #1,536 of 8,699 institutional investors

Tang Capital Management LLC

San Diego, CA

$1.92B
US stock portfolio at live prices · today −$28.5M (−1.46%)
Live prices, last trade 11:31 AM ET
Value at quarter end (Q3 2026)
$2.16B
Change from Q2 2026
−$27.7M (−1.27%)
Positions
42 · 5 new, 1 sold out
Filed
Nov 16, 2026

Not counted in the ranking: $11.2M of convertible notes and other principal-amount securities. $186M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
AUPH 10.1%SYRE 9.38%TARS 7.43%LKFT 6.90%MIRM 6.30%
StockSharesValue, live% of portfoliovs Q2 2026
AUPH Aurinia Pharmaceuticals Inc.13,044,106$193M10.1%Unchanged
SYRE Spyre Therapeutics, Inc.1,892,200$180M9.38%Unchanged
TARS Tarsus Pharmaceuticals, Inc.1,917,666$143M7.43%Added +22%
LKFT Lakefront Biotherapeutics NV3,985,991$133M6.90%Added +5%
MIRM Mirum Pharmaceuticals, Inc.1,236,027$121M6.30%Unchanged
CORT Corcept Therapeutics Incorporated1,500,000$95.2M4.95%Unchanged
PTCT PTC Therapeutics, Inc.1,500,000$86.7M4.51%Unchanged
CELC Celcuity Inc.1,464,594$80.0M4.16%Added +11%
IMCR Immunocore Holdings plc2,884,149$76.9M4.00%Added +9%
ANAB AnaptysBio, Inc.1,474,262$69.0M3.59%Added +11%
SPY State Street SPDR S&P 500 ETF Trust95,000$67.0M3.49%Reduced −23%
VRDN Viridian Therapeutics, Inc.1,792,626$55.2M2.87%Unchanged
ANIP ANI Pharmaceuticals, Inc.707,500$48.5M2.52%Unchanged
CMPS COMPASS Pathways plc5,200,000$42.2M2.20%Added +4%
BNTX BioNTech SE470,000$38.1M1.98%Unchanged
NVCT Nuvectis Pharma, Inc.1,577,968$30.4M1.58%Added +2%
PGEN Precigen, Inc.6,417,500$27.3M1.42%Unchanged
ARDX Ardelyx, Inc.9,047,134$27.1M1.41%New
FULC Fulcrum Therapeutics, Inc.7,080,945$26.2M1.36%Added +9%
NNDM Nano Dimension Ltd.20,926,847$22.6M1.18%Added +46%
DNTH Dianthus Therapeutics, Inc.264,692$22.3M1.16%Unchanged
AVIR Atea Pharmaceuticals, Inc.4,814,700$18.7M0.97%Unchanged
INSM Insmed Incorporated100,000$14.5M0.75%Unchanged
VERA Vera Therapeutics, Inc.500,000$12.9M0.67%New
VKTX Viking Therapeutics, Inc.500,000$12.7M0.66%Unchanged
NUVB Nuvation Bio Inc.3,299,557$12.6M0.66%Unchanged
CMPX Compass Therapeutics, Inc.17,990,782$12.1M0.63%Unchanged
IDYA IDEAYA Biosciences, Inc.450,000$11.7M0.61%Unchanged
LEGN Legend Biotech Corporation700,000$11.1M0.58%New
MRNA Moderna, Inc.50,000$10.0M0.52%Unchanged
STOK Stoke Therapeutics, Inc.300,000$8.2M0.43%Unchanged
BOLD Boundless Bio, Inc.2,840,635$6.6M0.34%Added +11%
DERM Journey Medical Corporation1,610,000$5.3M0.28%Unchanged
PMVP PMV Pharmaceuticals, Inc.7,285,085$5.2M0.27%Added +72%
PLRX Pliant Therapeutics, Inc.6,141,261$3.7M0.19%Unchanged
HRTX Heron Therapeutics, Inc.8,971,427$2.4M0.12%Added +44%
WVE Wave Life Sciences, Inc.600,000$1.6M<0.1%Unchanged
LENZ LENZ Therapeutics, Inc.451,114$1.4M<0.1%Unchanged
ALT Altimmune, Inc.666,022$912K<0.1%Unchanged
SION Sionna Therapeutics, Inc.125,000$361K<0.1%New
RCKT Rocket Pharmaceuticals, Inc.100,000$204K<0.1%Unchanged
SKYE Skye Bioscience, Inc.200,000$134K<0.1%New

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
CAPR Capricor Therapeutics, Inc.4,099,900$32.3M